Natalia V. Gomyranova

Moscow, MOW, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.

Insights from GWAS, TWAS, and DEG analysis: CDKN2B-AS1, MAP3K4, and P2RX2-encoded P2X2 receptor identified as potential therapeutic targets for ischemic heart disease in Russian adults and long-living individuals.

Journal: Frontiers in cardiovascular medicine

Published: March 26, 2026

Inclisiran Therapy and Lipid Profile Dynamics in Real-World Clinical Practice in Russia: Interim Results of an Observational Study.

Inclisiran Therapy and Lipid Profile Dynamics in Real-World Clinical Practice in Russia: Interim Results of an Observational Study.

Journal: Kardiologiia

Published: November 24, 2025

Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population.

Personalized polygenic profiling based on the genetic architecture of lipid metabolism in the Russian population.

Journal: Frontiers in cardiovascular medicine

Published: September 17, 2025

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease.

Prevalence and penetrance of pathogenic and likely pathogenic LDLR and APOB gene variants linked to familial hypercholesterolemia and increased risk of ischemic heart disease.

Journal: Frontiers in genetics

Published: March 06, 2025

A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report

A clinical case of reverse left ventricular remodeling in patient with pathogenic TTN mutation. Case report

Journal: Terapevticheskii arkhiv

Published: July 22, 2024

Laboratory Aspects of Using the Results of NT-Probnp Concentration Immunochemical Determination in the Management of Patients With Heart Failure: Support For Clinical Decision-Making

Laboratory Aspects of Using the Results of NT-Probnp Concentration Immunochemical Determination in the Management of Patients With Heart Failure: Support For Clinical Decision-Making

Journal: Kardiologiia

Published: June 11, 2024

Factors of Interleukin-6 Signaling in COVID-19 Patients with Lung Damage of Varying Degrees: A Pilot Study.

Factors of Interleukin-6 Signaling in COVID-19 Patients with Lung Damage of Varying Degrees: A Pilot Study.

Journal: Bulletin of experimental biology and medicine

Published: September 01, 2023

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Albuminuria as a marker of atherosclerosis burden and a possible predictor of adverse events in patients with polyvascular disease

Journal: Terapevticheskii arkhiv

Published: July 21, 2021

Subfractional Spectrum of Serum Lipoproteins and Gut Microbiota Composition in Healthy Individuals.

Subfractional Spectrum of Serum Lipoproteins and Gut Microbiota Composition in Healthy Individuals.

Journal: Microorganisms

Published: May 26, 2021

Efficiency of primary prevention for diseases caused by atherosclerosis in patients at high cardiovascular risk in Russia and other European countries (Part 2)

Efficiency of primary prevention for diseases caused by atherosclerosis in patients at high cardiovascular risk in Russia and other European countries (Part 2)

Journal: Kardiologiia

Published: February 22, 2018

Efficacy of primary prevention for atherosclerosis-induced diseases in patients with high cardiovascular risk in Russia and other European countries (Part 1)

Efficacy of primary prevention for atherosclerosis-induced diseases in patients with high cardiovascular risk in Russia and other European countries (Part 1)

Journal: Kardiologiia

Published: December 26, 2017

Drug Treatment of Patients With Ischemic Heart Disease in Russia and Europe: Results of Russian Part of the International Multicenter Study EUROASPIRE IV

Drug Treatment of Patients With Ischemic Heart Disease in Russia and Europe: Results of Russian Part of the International Multicenter Study EUROASPIRE IV

Journal: Kardiologiia

Published: March 15, 2017

Showing 1-12 of 12

Last Updated: 09/26/2026